Publication Brief
Reducing vascular access morbidity: a comparative trial of two vascular access monitoring strategies Lok CE et al, University of Toronto, Toronto, Ontario, Canada BACKGROUND Thrombosis is the primary cause of access failure in PTFE grafts and arteriovenous fistulas (AVFs) and can lead to significant patient and access morbidity and mortality. Detecting culprit lesions early and intervening with angioplasty or surgical revision is the primary intervention. This 3 year prospective study comparing Duplex ultrasonography (Duplex US) and saline ultrasound dilution technique (UD) in a large urban dialysis centre.
OBJECTIVE
To compare the efficacy of Duplex US and UD, each followed by radiological or surgical intervention to monitor grafts and fistulas, in order to detect access malfunction and prevent vascular access thrombosis. A secondary goal was to determine patient and access characteristics that predict access thrombosis.
METHODS
• Year 1: Duplex US was used to monitor all AVG every 6 months or more frequently for those accesses that appeared at risk for further stenosis or thrombosis. The nursing staff assessed AVFs at each dialysis session. Those that demonstrated evidence of stenosis by two of three criteria (abnormal physical exam, elevated venous pressures or abnormal monthly recirculation studies) were referred for a Duplex US exam. If the Duplex US found a severe stenosis, indicating a lesion of >50%, a referral for an angiogram was made. • Year 2: Transition year to using Transonic UD to monitor vascular accesses. • Year 3: Transonic UD became the primary monitoring strategy with 1516 flow studies performed. • Transonic study protocol: monthly measurements for AVG; bimonthly for AVFs. At least two flow measurements were obtained in the first hour of dialysis, when the patient was haemodynamically stable with a systolic blood pressure >110 mmHg at a blood flow rate of 300 ml/min. Qa measurements were averaged. If a low or declining flow, (<650mL/min for grafts or < 500 mL/min for AVFs or a drop of >15% compared with the previous measurement), referral for an angiogram and angioplasty or surgical revision was made. If the lesion was not severe (<50%), routine Transonic monitoring was resumed. • The primary end point of this study was the cumulative thrombosis rate at 14 and 30 days after access monitoring. Secondary end points were the cumulative procedure rates for angiograms, angioplasties and thrombolysis. Exploratory end points of interest included risk factors for thrombosis, the rate of accessrelated hospitalizations and the average length of stay of these hospitalizations.
RESULTS:
• Five hundred and forty eight accesses in 401 patients; 303,656 access days at risk were analyzed, 
TRANSONIC OBSERVATIONS
• Excellent comparison study of Transonic ultrasound dilution method versus Duplex ultrasound for detecting thrombosis in AV grafts and fistulas from a major institution.
